LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all patients with CLL involve therapy. In spite of all modern innovations, the iwCLL however endorses watchful observation for patients with asymptomatic disease.86 This advice is based on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104